Form 4: Tenet Healthcare Director Trades THC Stock

Meghan Fitzgerald, a Director at Tenet Healthcare Corp (THC), reported transactions involving restricted stock units and common stock.

Summary

• Director Meghan Fitzgerald of Tenet Healthcare Corp (THC) engaged in stock transactions on May 22, 2026.
• Fitzgerald acquired 1,333 shares of common stock through the settlement of restricted stock units (RSUs).
• These RSUs were economically equivalent to one share of THC common stock.
• The settlement involved 37% of the RSUs being converted to cash and 63% to shares.
• Additionally, Fitzgerald disposed of 493 shares of common stock for a price of $173.78 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine insider transactions without indicating significant positive or negative performance or strategic shifts.

Positives

• Director Fitzgerald acquired additional shares of common stock through RSU settlement, indicating continued equity ownership.
• The settlement of RSUs demonstrates a mechanism for executive compensation and equity alignment.

Negatives

• Director Fitzgerald disposed of 493 shares of common stock, which could be interpreted as a reduction in direct ownership.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which details past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the healthcare industry, providing transparency into executive and director stock activity.

Stakeholder Impact

• Shareholders: The disposal of shares by a director may be observed, though the acquisition of shares via RSU settlement also indicates continued equity participation.
• Management: The transaction reflects standard compensation and equity management practices for company leadership.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, SEC Filing, Director, Stock Transaction, Restricted Stock Units, Common Stock, Beneficial Ownership